List Title | APhA DrugInfoLine

Alternative Medicines Corner

SORT BY: Most Recent Most Viewed

May 29, 2018

Alternative treatment may be an option for patients with RA

READ

PREVIEW
Use of resveratrol as an adjunct therapy to conventional treatments in patients with rheumatoid arthritis (RA) resulted in a significant decrease in major clinical and biochemical markers of...
May 29, 2018

Selective androgen receptor modulators sold on the internet pose serious health risks

READ

PREVIEW
JAMA published an analysis of 44 products marketed as selective androgen receptor modulators (SARMs) sold on the internet. The majority of these products contained compounds not listed on...
March 20, 2018

Omega-3 fatty acid supplementation and CV benefits

READ

PREVIEW
Use of omega-3 fatty acids in high-risk patients did not result in any significant reductions in the risk of fatal or nonfatal coronary heart disease (CHD) or any major vascular events, according...
March 6, 2018

Herb–drug interactions can result in serious adverse drug reactions

READ

PREVIEW
Results of an extensive review demonstrated that use of herbal products by patients taking prescription or OTC medications (e.g., warfarin, statins, immunosuppressants, NSAIDs) resulted in adverse...
January 30, 2018

Ginkgo biloba may improve cognitive function postacute ischemic stroke

READ

PREVIEW
Administration of daily ginkgo biloba extract with aspirin to patients with an acute ischemic stroke resulted in better memory function, executive function, and neurological function compared with...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.